Cinven is reviewing strategic options for laboratory-services company Synlab International GmbH including a potential sale, people with knowledge of the matter said.
The private equity firm has been speaking with potential advisers and could start a sale process early next year, the people said, asking not to be identified because the information is private. Cinven plans to seek a valuation of about 5.5 billion euros ($6 billion) including debt for Augsburg, Germany-based Synlab, one of the people said.
A sale of Synlab would likely attract other private equity firms, the people said. No final decision has been made, and Cinven could elect to keep the business, the people said. A spokeswoman for Cinven declined to comment, while Synlab didn’t answer phone calls seeking comment.
Cinven first invested in Synlab in June 2015, buying a majority stake from fellow private equity firm BC Partners for about 1.7 billion euros, Bloomberg News reported at the time. It combined the business with Labco SA, which it agreed to buy earlier that year for 1.2 billion euros.
Synlab, led by Chief Executive Officer Mathieu Floreani, also counts Novo A/S and Ontario Teachers’ Pension Plan as minority investors, according to its website. It operates across more than 40 countries, handling more than 500 million clinical tests annually, according to Synlab’s website.
Cinven also owns stakes in retailer Kurt Geiger and German drugmaker Stada Arzneimittel AG, according to its website.
The sale plan comes at a time when Cinven’s rival Apax Partners is also weighing a sale of diagnostic services business Unilabs. The buyout firm is working with advisers at Rothschild & Co. to look at options for the business, people familiar with the matter said last week.
Source: Bloomberg
Can’t stop reading? Read more
Blackstone targets mid-April IPO for Cirsa in Madrid
Blackstone targets mid-April IPO for Cirsa in Madrid Blackstone is preparing to list shares of Spanish gambling company Cirsa in mid-April, aiming to complete the initial public offering before the Easter holiday, according to a report from Expansion citing unnamed...
Brookfield aims to raise $7bn for new infrastructure debt fund
Brookfield aims to raise $7bn for new infrastructure debt fund Brookfield Asset Management is targeting at least $7bn for its fourth infrastructure debt fund, expanding one of the largest strategies in the sector. The new fund will invest in both junior and senior...
Carlyle, Blackstone, and MBK lead bidding for HPSP’s $1.5bn semiconductor stake
Carlyle, Blackstone, and MBK lead bidding for HPSP’s $1.5bn semiconductor stake Global private equity giants Carlyle Group, Blackstone, and MBK Partners are among the frontrunners in the race to acquire a 40.9% stake in South Korean semiconductor equipment maker HPSP....